(Q60907369)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

title

Cross-lineage protection by human antibodies binding the influenza B hemagglutinin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Robyn Esterbauer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Adam K Wheatley

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

9

Aeron C Hurt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

author name string

Yi Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Marios Koutsakos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Sinthujan Jegaskanda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Danielle Tilmanis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Malet Aban

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Katherine Kedzierska

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Stephen J Kent

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

language of work or name

English

0 references

publication date

18 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

page(s)

324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

19 April 2020

copyright license

start time

18 January 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/s41467-018-08165-y

0 references

cites work

The burden of influenza B: a structured literature review

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Universal influenza virus vaccines and therapeutics: where do we stand with influenza B virus?

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Recurring influenza B virus infections in seals

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Animal models for influenza virus pathogenesis, transmission, and immunology

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Comparison of the mutation rates of human influenza A and B viruses

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

The contrasting phylodynamics of human influenza B viruses.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Genome-wide evolutionary dynamics of influenza B viruses on a global scale

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Human monoclonal antibodies broadly neutralizing against influenza B virus

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Highly Conserved Protective Epitopes on Influenza B Viruses

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Influenza virus antigenicity and broadly neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Structural basis for receptor specificity of influenza B virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Structural basis for the divergent evolution of influenza B virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/Yamagata

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Three Types of Broadly Reacting Antibodies against Influenza B Viruses Induced by Vaccination with Seasonal Influenza Viruses.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses.

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

A method for identification of HIV gp140 binding memory B cells in human blood

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

ViroSpot microneutralization assay for antigenic characterization of human influenza viruses

1 reference

https://api.crossref.org/works/10.1038%2FS41467-018-08165-Y

7 January 2021

Cross-reactive antibodies induced by a monovalent influenza B virus vaccine

1 reference

12 December 2020

Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test.

1 reference

12 December 2020

Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009.

1 reference

12 December 2020

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.

1 reference

12 December 2020

10.1038/S41467-018-08165-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

19 April 2020

ADS bibcode

2019NatCo..10..324L

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30659197%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

PubMed publication ID

30659197

1 reference